Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer

Background/Aims The combination of nab-paclitaxel and gemcitabine (nab-P/Gem) is widely used for treating meta-static pancreatic cancer (MPC). We aimed to evaluate the therapeutic outcomes and prognostic role of treatment-related peripheral neuropathy in patients with MPC treated with nab-P/Gem in c...

詳細記述

書誌詳細

主要な著者:	Min Su You, Ji Kon Ryu, Young Hoon Choi, Jin Ho Choi, Gunn Huh, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim
フォーマット:	Artigo
言語:	Inglês
出版事項:	Gastroenterology Council for Gut and Liver 2018-11-01
シリーズ:	Gut and Liver
主題:	pancreatic neoplasm metastasis chemotherapy gemcitabine nab-paclitaxel
オンライン･アクセス:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl18220
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!